The Amgenix extensive line of Rapid Point-Of-Care Diagnostics: OnSight™ and DrugSight™ deliver rapid and reliable results that can help improve clinical decision-making and optimal patient outcomes. Amgenix diagnostics focus on Women’s Health, Infectious Diseases, Cardiology, Oncology, Sexually-Transmitted Diseases, and Drugs of Abuse.

The MicroLISA assays are an EIA range including infectious serology markers, thyroid markers, fertility, cardiac, tumour/cancer markers as well as tests for drugs of abuse and therapeutic drug monitoring.

For more information about these products, visit the Amgenix website or e-mail us.